Pharmacological inhibition of β-catenin/BCL9 interaction overcomes resistance to immune checkpoint blockades by modulating T <sub>reg</sub> cells

Mei Feng, Joy Q. Jin, Lixiu Xia, Tengfei Xiao, Shenglin Mei, X. Wang, Xiaowu Huang, Jianmin Chen, Michael Liu, Chaohang Chen,

Science Advances · 2019 · 105 citations · 32 references

DOIFull text

Open access

Concepts

Abstract

mutation in colorectal cancers, it indicates our peptides can reactivate anti-cancer immune response suppressed by the oncogenic Wnt pathway. In summary, we report a promising strategy for cancer therapy by pharmacological inhibition of the Wnt/β-cat signaling.

References

32